Rao Mahendra, Mason Chris, Solomon Susan
New York Stem Cell Foundation, 3969 Broadway 4th floor, NYC, NY 10032, USA.
Regen Med. 2015;10(2):181-91. doi: 10.2217/rme.14.80.
The regenerative medicine field is large, diverse and active worldwide. A variety of different organizational and product models have been successful, and pioneering entrepreneurs have shown both what can work and, critically, what does not. Evolving regulations, novel funding mechanisms combined with new technological breakthroughs are keeping the field in a state of flux. The field struggles to cope with the lack of infrastructure and investment, it nevertheless has evolved from its roots in human stem cell therapy and tissue and organ transplants to a field composed of a variety of products from multiple cell sources with approval for use in numerous countries. Currently, tens of thousands of patients have been treated with some kind of cell therapy.
再生医学领域在全球范围内规模庞大、种类多样且充满活力。多种不同的组织和产品模式都已取得成功，开创性的企业家们既展示了可行的做法，也至关重要地揭示了不可行的做法。不断演变的法规、新颖的融资机制以及新的技术突破，使该领域一直处于变化之中。该领域在努力应对基础设施和投资不足的问题，不过它已从人类干细胞治疗以及组织和器官移植的根源，发展成为一个由来自多种细胞来源的各类产品组成的领域，这些产品已在众多国家获批使用。目前，数以万计的患者已经接受了某种细胞疗法的治疗。
